Are Biotech Companies Strong Investments?

Clinipace CEO, Jason Monteleone, CPA, CMA, MBA, analyzes the increases in capital raised by biotech companies that have gone public, thus improving the economy and patient outcomes in this Contract Pharma article. Read more.

Back to News